These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7533698)

  • 1. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
    Lee CR; Balfour JA
    Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
    Scarpignato C
    Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
    Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
    Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
    Serni U
    Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
    Dolci G; Ripari M; Pacifici L; Umile A
    Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
    Lister RE; Acerbi D; Cadel S
    Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.
    Todd PA; Clissold SP
    Drugs; 1991 Apr; 41(4):625-46. PubMed ID: 1711963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
    Wang D; Miller R; Zheng J; Hu C
    J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclic molecules and their pharmacological applications.
    Lasagna L
    Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis.
    Bonardelli P; Oliani C; Monici Preti PA; Pellicanó P; Quattrocchi G
    Clin Ther; 1990; 12(6):547-55. PubMed ID: 2289222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
    Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
    Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
    Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
    Dolci G; Ripari M; Pacifici L; Umile A
    Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.